TRIPHENYLSTANNYL ACETATE


Synonyms	Triphenylstannyl Acetate
UNII	70M92GQA9T
Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C20H18O2Sn
Molecular Weight	409.07
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Assay Description	Organism	Bioactivity
Insecticidal activity against drug-resistant Plutella xylostella (diamondback moth) fourth-instar larvae exposed to compound through topical application followed by transfer onto fresh Brassica leaves assessed as insect mortality measured 48 hr post compound application	Plutella xylostella	6.06 10'-3 mol/L
Antifeedant activity against Spodoptera littoralis fifth-instar larvae reared on compound exposed lettuce disks assessed as feeding ratio when 50% of control leaf disk area consumed at 10 ug/cm2 measured for 4 to 5 hr by leaf disk choice method	Spodoptera littoralis	0.37
Antifeedant activity against newly ecdysed fifth-instar larval stage of Spodoptera littoralis in compound-pretreated lettuce leaf disks assessed as consumed area of leaf disks at 10 ug/cm'2 measured at 30 min intervals for 4-5 hr post-drug exposure by choice test	Spodoptera littoralis	0.37

Cross References

Resources	Reference
ChEMBL	CHEMBL474376
FDA SRS	70M92GQA9T
PubChem	16682804
SureChEMBL	SCHEMBL68978

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).